Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Clostridioides difficile Infection

moxifloxacin has been researched along with Clostridioides difficile Infection in 39 studies

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (7.69)29.6817
2010's26 (66.67)24.3611
2020's10 (25.64)2.80

Authors

AuthorsStudies
Abdrabou, AMM; Berger, FK; Bischoff, M; Gärtner, BC; Margardt, L; Mellmann, A; von Müller, L1
Adamczyk, M; Albrecht, V; Anderson, KF; Campbell, D; Elkins, CA; Gargis, AS; Guh, AY; Halpin, AL; Karlsson, M; Kent, AG; Korhonen, LC; Lutgring, JD; McAllister, G; McDonald, LC; McKay, SL; Paulick, AL; Rasheed, JK; Vlachos, N1
Kim, B; Kim, J; Pai, H1
Kopilec, MG; Kotlebova, N; Krutova, M; Kuijper, E; Novak, M; Novakova, E; Stefkovicova, M1
Andremont, A; Chilton, CH; Crowther, GS; de Gunzburg, J; Miossec, C; Wilcox, MH1
Cheng, JW; Fan, X; Hou, X; Kudinha, T; Liang, GW; Liu, C; Shao, DH; Su, JR; Wang, Y; Wei, M; Xiao, M; Xiong, ZJ; Xu, YC; Yang, CX; Yang, QW; Yu, SY1
Balejova, M; Capek, V; Cermak, P; Curdova, M; Drevinek, P; Geigerova, L; Havlinova, L; Jezek, P; Krutova, M; Kucharova, A; Nemcova, D; Nyc, O; Nycova, E; Ryskova, L; Tejkalova, R; Vagnerova, I; Vesela, D; Vojackova, S; Zamazalova, D1
Dzhandarova, DT; Mironov, AY; Mitrokhin, SD; Shvydkaya, MG; Zatevalov, AM1
LaPensee, K; Lodise, TP; Mistry, R; Young, K1
Jane, F; Jon J, V; Mark H, W1
Jalava, J; Krutova, M; Kuijper, EJ; Matejkova, J; Mentula, S; Nyc, O1
Cheng, JW; Kong, F; Kudinha, T; Liao, JW; Xiao, M; Xu, YC; Yang, QW; Yu, SY; Zhou, ML1
Cai, L; Feng, P; Liu, X; Wang, X; Yang, J; Zhang, X; Zong, Z1
Chen, YB; Fang, YH; Gu, SL; Li, LJ; Lv, T; Shen, P; Tang, LL1
Araj, GF; Becker, SL; Berger, FK; Bischoff, M; Dbaibo, G; Gärtner, B; Karaoui, WR; Mahfouz, R; Matar, GM; Rasheed, SS; Rimmani, HH; Sharara, AI; von Müller, L1
Bernardy, J; Faldyna, M; Krejčí, J; Krutova, M; Matejkova, J; Nyc, O; Tkadlec, J; Zouharova, M1
Andremont, A; Burdet, C; Corbel, T; de Gunzburg, J; Ferreira, S; Hugon, P; Mentré, F; Nguyen, TT; Pulse, M; Sablier-Gallis, F; Saint-Lu, N; Sayah-Jeanne, S; Weiss, W1
Chopra, V; Conlon, A; Flanders, SA; Gandhi, T; Malani, AN; Vaughn, VM1
Berger, F; Jazmati, N; Piepenbrock, E; Stelzer, Y1
Goering, RV; Lynn, AN; Persing, DH; Tenover, FC; Tickler, IA; Whitmore, JD1
Balassiano, IT; Boente, RF; Brazier, J; Domingues, RM; dos Santos-Filho, J; Hall, V; Lobo, LA; Miranda, KR; Nouér, SA; Secco, DA1
Chott, A; Equiluz-Bruck, S; Fudel, M; Reiter, I; Schmid, A; Singer, E; Wenisch, JM1
Carter, GP; Elliott, B; Howden, BP; Jenkin, GA; Korman, TM; Kotsanas, D; Lyras, D; Mackin, KE; Riley, TV; Rood, JI1
Freeman, J; Vernon, J; Vickers, R; Wilcox, MH1
del Mar Gamboa-Coronado, M; López-Ureña, D; Montoya-Ramírez, M; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E; Somogyi, T1
Abratt, V; Kullin, B; Reid, SJ; Wojno, J1
Kriz, Z; Krutova, M; Kubicek, L; Kuijper, E; Matejkova, J; Nyc, O; Ruzicka, F; Tejkalova, R1
Simoens, S1
Alcantara-Warren, C; Archbald-Pannone, L; Carman, RJ; Genheimer, CW; Gerding, DN; Guerrant, RL; Lyerly, D; Pawlowski, SW1
Boyd, DA; Gravel, D; Hutchinson, J; McGeer, A; Miller, M; Moore, D; Mulvey, MR; Simor, A; Suh, K; Taylor, G; Walkty, A1
Donskey, CJ; Ellis-Reid, T; Gerding, DN; Jump, RL; Pultz, MJ; Riebel, W; Riggs, MM; Salata, RA; Sethi, AK1
Gerding, DN; Johnson, S; Nagaro, K; Phillips, ST; Sambol, SP1
Barbanti, F; Mastrantonio, P; Spigaglia, P1
Alder, JD; Citron, DM; Goldstein, EJ; Solomkin, JS1
Borgmann, S; Gruber, H; Hensgens, MP; Jakobiak, T; Kist, M; Kuijper, EJ; Reil, M1
Kang, JO; Kim, J; Pai, H; Seo, MR1
Farina, C; Russello, G; Russo, A; Scaltrito, MM; Sisto, F1
Fortier, LC; Meessen-Pinard, M; Sekulovic, O1
Gottlieb, T; Leroi, MJ; Siarakas, S1

Reviews

1 review(s) available for moxifloxacin and Clostridioides difficile Infection

ArticleYear
Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.
    Current medical research and opinion, 2009, Volume: 25, Issue:10

    Topics: Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cost-Benefit Analysis; Diarrhea; Drug Resistance, Microbial; Economics, Pharmaceutical; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Practice Guidelines as Topic; Quinolines

2009

Other Studies

38 other study(ies) available for moxifloxacin and Clostridioides difficile Infection

ArticleYear
Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021.
    Anaerobe, 2022, Volume: 77

    Topics: Anti-Bacterial Agents; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Rifampin; Sentinel Surveillance

2022
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 03-04, Volume: 76, Issue:5

    Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Genomics; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; United States; Vancomycin

2023
Diversity of binary toxin positive Clostridioides difficile in Korea.
    Scientific reports, 2023, 01-11, Volume: 13, Issue:1

    Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Republic of Korea; Toxins, Biological

2023
The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 90

    Topics: Adolescent; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Incidence; Infant; Male; Moxifloxacin; Ribotyping; Slovakia

2020
Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model.
    The Journal of antimicrobial chemotherapy, 2020, 06-01, Volume: 75, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium; Clostridium Infections; Gastrointestinal Tract; Humans; Moxifloxacin

2020
The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; China; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA Gyrase; Drug Resistance, Bacterial; Enterotoxins; Fluoroquinolones; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Moxifloxacin; Vancomycin

2020
The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.
    Antimicrobial resistance and infection control, 2020, 06-30, Volume: 9, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Czech Republic; Feces; Female; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping

2020
[Peptide imunofan and moxifloxacin combined effects on toxigenic strain Clostridium difficile in vitro.]
    Klinicheskaia laboratornaia diagnostika, 2020, Jul-20, Volume: 65, Issue:8

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Oligopeptides

2020
Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile Infection.
    Clinical drug investigation, 2021, Volume: 41, Issue:3

    Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Clostridium Infections; Community-Acquired Infections; Hospitalization; Humans; Moxifloxacin; Pneumonia, Bacterial; Tetracyclines

2021
Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
    Anaerobe, 2021, Volume: 70

    Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; United Kingdom; Vancomycin

2021
The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:3

    Topics: ADP Ribose Transferases; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Base Sequence; Clostridioides difficile; Clostridium Infections; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Enterotoxins; Female; Finland; Fluoroquinolones; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Molecular Epidemiology; Moxifloxacin; Multilocus Sequence Typing; Polymerase Chain Reaction; Repressor Proteins; Ribotyping; Young Adult

2018
High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; China; Clostridioides difficile; Clostridium Infections; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Hospitals, Teaching; Hospitals, University; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Tigecycline; Vancomycin

2018
Antimicrobial susceptibility of Clostridium difficile isolates from ICU colonized patients revealed alert to ST-37 (RT 017) isolates.
    Diagnostic microbiology and infectious disease, 2017, Volume: 89, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Enterotoxins; Fluoroquinolones; Humans; Intensive Care Units; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Quinolones

2017
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China.
    Journal of medical microbiology, 2018, Volume: 67, Issue:1

    Topics: Anti-Infective Agents; Bacterial Proteins; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Moxifloxacin; Tertiary Care Centers; Vancomycin

2018
Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    International journal of medical microbiology : IJMM, 2018, Volume: 308, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Fluoroquinolones; Humans; Lebanon; Male; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Phenotype; Ribotyping; Vancomycin

2018
The emergence of Clostridium difficile PCR ribotype 078 in piglets in the Czech Republic clusters with Clostridium difficile PCR ribotype 078 isolates from Germany, Japan and Taiwan.
    International journal of medical microbiology : IJMM, 2018, Volume: 308, Issue:7

    Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; Germany; Japan; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Swine; Taiwan; Tetracycline; Vancomycin

2018
Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Cricetinae; Dysbiosis; Gastrointestinal Microbiome; Male; Mesocricetus; Moxifloxacin

2018
The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 09-27, Volume: 69, Issue:8

    Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Ciprofloxacin; Clostridium Infections; Cohort Studies; Drug Prescriptions; Drug Resistance, Bacterial; Female; Fluoroquinolones; Hospitals; Humans; Levofloxacin; Male; Michigan; Moxifloxacin; Pneumonia; Retrospective Studies; Risk; Surveys and Questionnaires

2019
Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.
    Current microbiology, 2019, Volume: 76, Issue:4

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Epidemiological Monitoring; Feces; Germany; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; Tertiary Care Centers; Vancomycin

2019
Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:7

    Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Feces; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; United States; Vancomycin; Vancomycin Resistance

2014
Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain.
    Anaerobe, 2014, Volume: 28

    Topics: Adult; Anti-Bacterial Agents; Bacterial Toxins; Brazil; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Bacterial; Enzyme-Linked Immunosorbent Assay; Feces; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Moxifloxacin; Ribotyping

2014
Decreasing Clostridium difficile infections by an antimicrobial stewardship program that reduces moxifloxacin use.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Austria; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Drug Utilization; Female; Fluoroquinolones; Hospitals; Humans; Infection Control; Male; Moxifloxacin; Ribotyping

2014
Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia.
    Anaerobe, 2015, Volume: 34

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fluoroquinolones; Genetic Variation; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Vancomycin; Victoria

2015
Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Benzimidazoles; Ceftriaxone; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Fidaxomicin; Fluoroquinolones; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Phenotype; Pyridines; Ribotyping; Vancomycin

2016
Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
    Emerging microbes & infections, 2016, May-11, Volume: 5

    Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Communicable Diseases, Emerging; Costa Rica; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Ribotyping; Time Factors; Vancomycin

2016
Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017, Volume: 36, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Disk Diffusion Antimicrobial Tests; Enterotoxins; Erythromycin; Female; Fluoroquinolones; Hospitals, Chronic Disease; Humans; Infant; Infant, Newborn; Male; Middle Aged; Minisatellite Repeats; Molecular Epidemiology; Moxifloxacin; Ribotyping; Rifampin; South Africa; Young Adult

2017
Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:5

    Topics: Aged; Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Capillary; Female; Fluoroquinolones; Gene Expression; Humans; Male; Methyltransferases; Metronidazole; Microbial Sensitivity Tests; Minisatellite Repeats; Moxifloxacin; Multilocus Sequence Typing; Retrospective Studies; Ribotyping; Tertiary Care Centers; Vancomycin

2017
Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.
    The Journal of hospital infection, 2009, Volume: 73, Issue:2

    Topics: Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Feces; Fluoroquinolones; Humans; Inflammation; Intestines; Lactoferrin; Microbial Sensitivity Tests; Moxifloxacin; Quinolines

2009
Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.
    Diagnostic microbiology and infectious disease, 2010, Volume: 66, Issue:4

    Topics: Amino Acid Substitution; Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Bacterial Typing Techniques; Canada; Clostridioides difficile; Clostridium Infections; DNA Fingerprinting; DNA Gyrase; DNA Mutational Analysis; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Mutation, Missense; Polymerase Chain Reaction; Quinolines; Sequence Analysis, DNA

2010
Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA.
    Emerging infectious diseases, 2010, Volume: 16, Issue:5

    Topics: Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Feces; Fluoroquinolones; Gatifloxacin; Genes, Bacterial; Hospitals; Humans; Moxifloxacin; Ohio; Quinolines

2010
Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.
    Anaerobe, 2011, Volume: 17, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Cricetinae; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Male; Mesocricetus; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Prohibitins; Quinolines

2011
Multidrug resistance in European Clostridium difficile clinical isolates.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:10

    Topics: Anti-Bacterial Agents; Aza Compounds; Clindamycin; Clostridioides difficile; Clostridium Infections; DNA Transposable Elements; DNA, Ribosomal; Drug Resistance, Multiple, Bacterial; Erythromycin; Europe; Fluoroquinolones; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Moxifloxacin; Quinolines; Ribosomal Proteins; Rifampin; RNA, Ribosomal, 23S; Tetracycline

2011
Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 53, Issue:11

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides Infections; Clostridium Infections; Fluoroquinolones; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome

2011
Seasonality of Clostridium difficile infections in Southern Germany.
    Epidemiology and infection, 2012, Volume: 140, Issue:10

    Topics: Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cluster Analysis; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genotype; Germany; Humans; Moxifloxacin; Quinolines; Ribotyping; Seasons

2012
Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections.
    BMC infectious diseases, 2012, May-09, Volume: 12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Bacterial Toxins; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Microbial; Enterotoxins; Feces; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Risk Factors; Severity of Illness Index; Treatment Outcome

2012
Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.
    The new microbiologica, 2012, Volume: 35, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Aza Compounds; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Bacterial; Enterotoxins; Feces; Female; Fluoroquinolones; Genes, Bacterial; Glutamate Dehydrogenase; Humans; Immunoenzyme Techniques; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Prevalence; Quinolines; Ribotyping; Sensitivity and Specificity; Young Adult

2012
Evidence of in vivo prophage induction during Clostridium difficile infection.
    Applied and environmental microbiology, 2012, Volume: 78, Issue:21

    Topics: Anti-Bacterial Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA, Viral; Feces; Fluoroquinolones; Genetic Variation; Genome, Viral; Humans; Levofloxacin; Lysogeny; Microbial Sensitivity Tests; Mitomycin; Molecular Sequence Data; Moxifloxacin; Myoviridae; Ofloxacin; Prophages; Quinolines; Sequence Analysis, DNA; Virus Activation

2012
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:1

    Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin

2002